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Summary 
We have created embryonic stem (ES) cells and mice lacking the predominant isoform (or) of 
the calcineurin A subunit (CNAc~)  to study the role of this serine/threonine phosphatase in the 
immune system. T  and B cell maturation appeared to be normal in CNAct  -/- mice. CNAc~  -/- 
T  cells responded normally to mitogenic stimulation (i.e., PMA plus ionomycin, concanavalin 
A, and anti-CD3e antibody). However, CNAot -/- mice generated defective antigen-specific T 
cell responses in vivo. Mice produced from CNAot -/- ES cells injected into RAG-2-deficient 
blastocysts had a similar defective T  cell response, indicating that CNAot is required for T  cell 
function per se, rather than for an activity of other cell types involved in the immune response. 
CNAoL -/- T  cells remained sensitive to both cyclosporin A and FK506, suggesting that CNA[3 
or another  CNA-hke  molecule  can mediate  the  action  of these  immunosuppressive drugs. 
CNAc, -/-  mice  provide  an  animal  model  for  dissecting  the  physiologic  functions  of cal- 
cineurin as well as the effects of FK506 and CsA. 
C 
alcineurin, also known as protein phosphatase 2B, is a 
calcium-  and  calmodulin-dependent  serine/threonine 
protein phosphatase (1, 2). It is expressed in all mammalian 
tissues  examined and is most abundant in the brain (2).  In 
lymphocytes, calcineurin is the major soluble calmodulin- 
binding protein (3). Calcineurin is a heterodimer consisting 
of a catalytic subunit  (CNA1; 61  kD) and a regulatory sub- 
unit (CNB; 19 kD). The phosphatase activity of the A sub- 
unit is regulated by calcium through both calmodulin and 
the B subunit (4). There are two genes encoding closely re- 
lated (N80% identical)  CNA subunit isoforms, CNAcx and 
CNA[3,  in the  mouse, human,  and rat genomes (5-8 and 
our unpublished  data).  The r  isoform is the predominant 
isoform found in brain, thymus, and T  cells  (1,  9,  10,  and 
our  unpublished  data).  Even  though  CNAcx  and  CNA[3 
1Abbreviations used in this paper: CNA, A subunit of calcineurin; CNAa, 
CNA[3, isoforms  of CNA; EF, embryonic  fibroblast  cells; ES, embryonic 
stem cells; ne0, neomycin  phosphotransferase  gene; tk, thyrmffme kinase gene. 
have similar functions in vitro, the physiologic functions of 
the different calcineurin A isoforms are not yet defined. 
CsA and  FK506  are  immunosuppressive drugs  used  to 
prevent graft rejection after organ transplantation.  In vitro 
studies  from several groups  have suggested that  CsA  and 
FK506 exert their immunosuppressive effects by inhibiting 
calcineurin's  phosphatase  activity  (11-15).  Complexes 
formed by  CsA  and  FK506  and  their  respective binding 
proteins inhibit calcineurin's phosphatase activity (16-18). 
This loss of phosphatase activity correlates with inhibition 
ofT cell activation (19). 
To distinguish the roles of CNAcr  and CNA[3 in T  cell 
activation,  we  generated  embryonic  stern  (ES)  cells  and 
mice lacking a functional  CNAa  gene.  The  composition 
and distribution ofT cell subsets were normal in CNAcx  -/- 
mice. CNAcr -/- and wild-type T  cells displayed similar re- 
sponses to mitogenic stimulation.  Surprisingly,  CNAc~ -/- 
mice  gave  deficient  in  vivo  antigen-specific  T  cell  re- 
sponses. The residual CNA[3 activity in CNAcx  -/- T  cells 
cannot  substitute  for  CNAot  activity in  the  immune  re- 
sponse.  CNAc~  -/-  T  cells  remained sensitive to  CsA and 
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can mediate the action of CsA and FK506 in T  cells. 
Materials  and Methods 
Construction of Targeting Vectors.  The targeting construct used 
to  disrupt the  CNAc~ gene was  designed for implementing the 
double-selection technique previously described (20, 21). Murine 
CNA(x cDNA was cloned by PCR. amplification (22) from mouse 
brain total cDNA using primers corresponding to CNAoL cDNA 
sequence (reference 8; GenBank accession No. J05479). The mu- 
rine CNAo~  cDNA was used to screen a  129/SVJ  liver genomic 
library (Stratagene, La Jolla, CA). A bacteriophage clone encod- 
ing part of the CNAot catalytic domain (8) was isolated and desig- 
nated MCAL-1. A  13-kb EcoRI fragment from clone MCAL-1 
was  subcloned into Bluescript containing the  thymidine kinase 
gene (tk) (21).  The intron-exon boundaries of this genomic frag- 
ment were defined by restriction enzyme site mapping and nucle- 
otide  sequence analysis (22).  The  neomycin phosphotransferase 
gene (neo) was inserted into an MluI site in the  exon encoding 
nucleotides 572-717 of the mouse CNAot mRNA sequence (8). 
Both neo and tk were under the control of the phosphoglycerate 
kinase promoter. 
Transfection and Selection of Mutant ES Cells.  J1  ES  cells  were 
grown on feeder layers of ~-irradiated embryonic fibroblast (EF) 
cells as described (23).  1.5-2 ￿  107 J1  cells at passage  9-10 were 
trypsinized and resuspended in 1 ml ofelectroporation buffer (24) 
that had been modified to contain 137 mM NaC1. 50 I~g of con- 
struct DNA was introduced into J1  ES  cells by electroporation. 
The ES cells were then grown in G418 and 1-[2-deory,2-fluoro- 
beta-D  arabinofuranosyl]-5-ioduracil (FIAU) as described previ- 
ously (23).  Surviving clones were picked 8-10 d  after selection, 
and DNA was extracted for Southern blot analysis. 
Generation of Germline Chimeras.  Heterozygous ES  cells  were 
injected into C57BL/6J blastocysts and reimplanted into the uteri 
of Black  Swiss  pseudo pregnant female  mice  as  described  (25). 
Agouti male offspring (derived from the 129 ES cells) were mated 
to  Black Swiss  or C57BL/6J  females.  Germline transmission of 
the mutated allele of the CNAo~ gene was monitored by Southern 
blot analysis of tail DNA from the agouti F1 offspring (see Fig. 1). 
Homozygous CNAot  /- mice were obtained by mating the het- 
erozygous CNAo~ +/-  mice.  The  mice  used in the  experiments 
presented  here  were  8-10  wk  old,  of either  Black  Swiss/129 
background or ofB6/129 background, as noted. 
Generation  of  CNA~-/-ES  Cells  and  CNAo~ -/  ~RAG-2 -l- 
Chimeras.  Homozygous  mutant ES  cells  were  generated  from 
heterozygous CNAot  +/- ES cells as described (21) with the follow- 
ing modification: 1-2 ￿  106 heterozygous knockout ES cells from 
a single clone were plated onto each 10-cm plate on G418-resistant 
EF cells in leukemia inhibitory factor (LIF)-supplemented (1,000 
U/ml) media. After 12  h,  1.5  p,g dry powder G418 was  added 
per milliliter of culture. After 4-6 d of G418 selection, surviving 
colonies were picked and the structure of the CNAol gene was as- 
sessed by Southern blot analysis. 
CNA~x -/- ES  cells  were  injected into RAG-2  -/-  blastocysts 
(26)  of either B6/129  or  FvB background to  generate  somatic 
chimeras  (27).  The ES  cell contribution to the chimera was as- 
sessed  by coat  color  (for mice bred into the  FvB background), 
and by quantification of peripheral blood CD4 + and CD8 + lym- 
phocytes. Chimeras used in experiments were 10 wk old. 
CytofluorometricAnalyses.  The  thymus,  lymph  nodes,  and 
spleen were isolated from wild-type, CNAot -/-, and CNAot-/-/ 
RAG-2  -/- mice, and tissues were dissociated into single-cell sus- 
pensions. RBC  were  lysed by the  addition of 1-5  rnl of Tris/ 
NH4C1 solution for 5 min at room temperature. Cell suspensions 
were filtered with a nylon mesh and washed twice with staining 
medium  (HBSS  with reduced  phenol  red,  sodium azide,  BSA, 
and EDTA). 0.5  ￿  106 cells were resuspended in 25  p~l staining 
medium and incubated for  15  rain on ice with  1 p,g of PE- or 
FITC-labeled antibodies (PharMingen, San Diego, CA) in 10 p2 
staining medium. Cells were washed  once and fixed with 0.5% 
formamide in staining medium. Flow cytometry was carried out 
using a  flow cytometer  (Cytofluorograf IIs; Becton-Dickinson, 
San Jose, CA). Each analysis recorded 20,000 cells. 
H-2 Genotyping.  The  presence  of H-2  b alleles  in the  wild- 
type and CNA~t  -/- mice of Black Swiss/129 background was as- 
certained by PC1L amplification of an l-E(x  b fragment (28)  using 
the  following  primers:  E~5'  (AGTCTTCCCAGCCTTCAC- 
ACTCAGAGGTAC) and E,~3' (CATAGCCCCAAATGTCTG- 
ACCTCTGGAGAG) (28a). 
In  Vivo Immunization and In  Vitro T  Cell Proliferation and Cyto- 
kine Production Assays.  8-10-wk-old  wild-type  and  CNA~ -/- 
mice of Black Swiss/129 background were immunized with 300 
txg  of trinitrophenol (TNP)-conjugated OVA  in CFA via foot 
pad  injection (29).  10  d  after  immunization, lymph node  cells 
were harvested. 2  ￿  10  s lymph node cells per well were cultured 
in triplicates in 96-well plates containing OVA alone, OVA plus 
2  ￿  10  s T  cell-depleted and irradiated C57BL/6 spleen cells  (as 
sources of exogenous APCs), or with OVA plus 10 U/ml IL-2. 
60 h after stimulation, 1 b~Ci [3H]thymidine was added per well, 
and incorporated radioactivity was assayed 6 h later. 
T  cell-derived cytokines were measured using standard proce- 
dures  (30).  Lymph node cells  from immunized mice were  har- 
vested and cultured with 1 rag/m] OVA. Supernatants from 2  ￿ 
10  s  cells/200  ~zl per well in 96-well plate were  harvested after 
24 h. The IL-2 activity in the supernatauts was measured by pro- 
liferation  of  HT-2  cells  in  the  presence  of otIL-4  antibody 
(11B11). At 24 h, the HT-2 culture was pulsed with 1 p,  Ci/well 
of [3H]thymidine for 6 h. Supernatants from 6 ￿  105 cells/200 ml 
per 96-well were harvested after 60 h. The amounts of IFN-',/in 
the supernatants were measured by ELISA. 
To assay polyclonal T  cell responses, spleen and lymph node 
cells from wild-type and CNAo~ -/  mice of Black Swiss/129 back- 
ground were  harvested  and  cultured  in  duplicates  at  2  ￿  l0  s 
cells/well with 2.5 ng/ml PMA plus 75 ng/ml ionomycin, or 2.5 
p~g/ml  ConA,  or  soluble  oLCD3e  antibody  (1:500  dilution of 
145.2C11 hybridoma supematant) (sCD3), or plate-bound o~CD3e 
antibody (plate coated with  10  I~g/ml of purified c~CD3e anti- 
body)  (x-CD3).  After 60 h  of stimulation, cultures were pulsed 
with 1 b~Ci/well [3H]thymidine for 6 h. 
Assessment of Calcineurin in T  Cells.  Spleen  and lymph nodes 
harvested  from  wild-type  and  CNAc~ -/-  mice  were  dispersed 
into  single-cell suspensions.  Pd3C  were  removed  by  lysis  (see 
above). The cell concentrations were adjusted to  1.5-2.0  ￿  10  ~ 
in 2 ml of PBS containing 5% FCS and 4 mM EDTA. The cell 
suspensions were  enriched for T  ceils  using Mouse T  Cell En- 
richment Columns (R&D Systems, Inc., Minneapolis, MN). The 
T cells were lysed in buffer containing 50 mM Tris-HC1, pH 7.5, 
15% glycerol, 0.1 mM EGTA, 1 mM EDTA, 0.5 mM DTT, 50 
p~g/ml  PMSF,  50  p,g/ml  soybean  trypsin  inhibitor,  5  p,g/ml 
aprotinin, and 5 ~g/ml leupeptin. Aliquots of 8 ￿  106 cells/50 p~l 
oflysis buffer were frozen until further analysis. 
The amount of calcineurin Ao~ in T  cell extracts was assessed 
by Western blots (31).  20 I~g of T  cell extract were fractionated 
by SDS-PAGE  on a  16%  Tris/glycine gel  (Novex,  San Diego, 
414  T Cell Responses in Calcineurin Aot-deficient Mice CA) at 150 V  (constant voltage) and transferred to a polyvinyldi- 
fluoride membrane (Immobilon) at 100 V  for 1.5 h. After trans- 
fer,  the  membrane was  blocked overnight in M-Blotto at  4~ 
The membranes were briefly rinsed in PBS and reacted with ei- 
ther rabbit antibody R2929  (specific  for  COOH-terminal pep- 
tide,  SNSSNIQ from human CNAcx)  or rabbit antibody R2948 
(specific  for CNA[3 residues 386-396, LMTEGEDEFDG). Rab- 
bit  antipeptide  antiserum was  diluted  to  1:10,000.  The  mem- 
branes  were  washed  and  HPR-conjugated  donkey  anti-rabbit 
secondary antibody diluted  1:10,000  (Amersham Corp.,  Arling- 
ton Heights,  IL).  The membranes were washed in Tris-buffered 
saline Tween (TBST) and developed with the enhanced chemilu- 
minescence Western blotting detection system (Amersham). 
Calcineurin Phosphatase Assay.  The  phosphatase  assay  was  as 
described in Martin and Wiederrecht (32). 
Results 
Generation  of CNAee -/-  Mice.  Calcineurin  A0t  knock- 
out (CNAoe -/-)  mice were produced by standard methods 
(25) after homologous recombination in ES cells. The gene 
targeting vector was  constructed by inserting the  neo gene 
into an exon  that  encodes part  of the  calcineurin catalytic 
domain and by inserting the  tk gene outside  the region of 
homology (Fig.  1  a).  Linearized construct DNA  was trans- 
fected into J1  ES  cells and colonies were  selected for neo- 
mycin and FIAU resistance (21, 23).  DNA  from individual 
clones was  analyzed by Southern blot  analysis after  diges- 
tion  with  MscI  and  hybridization with  the  1.2-kb  probe 
(Fig.  1).  A  novel  7.5-kb  fragment,  as  well  as  the  18-kb 
fragment found in wild-type ES  cell DNA,  were  found in 
CNAo~ +/- ES cell DNA  (Fig.  1 b; data not shown). 
Heterozygous  CNA0t +/-  ES  cells  were  then  injected 
into  C57BL/6  blastocysts  and  some  of the  resultant  chi- 
meric mice passed the mutated gene onto the next genera- 
tion  when  mated  with  Black  Swiss  or  C57BL/6  mice. 
CNAcx -/-  mice were obtained by mating the heterozygous 
CNA~x +/- mice. 
Generation  of CNAa-/-/RAG-2  -/-  Chimeras.  CNAcx +/- 
ES cells were grown in 1.5 mg/ml  G418 to select ES cells 
lacking both copies of functional CNAot genes (21). DNA 
was  extracted  from  surviving  clones  and  analyzed  by 
Southern  analysis.  CNAot -/-  clones  were  identified  by 
their lack of the endogenous 18-kb MscI fragment (Fig. 1 b 
and  data  not  shown).  The  functional  disruption  of  the 
CNA~x  gene was  confirmed by lack of CNAa  expression 
in CNA~x -/-  ES  cells.  RNA  from  wild-type,  CNAo~ +/-, 
and  CNAoL -/-  ES  cells  were  characterized  by  Northern 
blot analysis using the  5'  end of CNAo~  cDNA  (reference 
8;  nucleotides 95-714)  as probe.  CNAot  mP,.NA was  de- 
tected in wild-type ES cells and in CNAcx +/- ES cells, but 
not in CNAoL -/-  ES cells (Fig.  1 c). 
CNAcx -/-  ES cells were injected into RAG-2 -/-  blasto- 
cysts of either B6/129  or FvB background to  generate so- 
matic chimeras (27).  In RAG-2 -/-  mice, there are no ma- 
ture  T  and B  cells  because  of the  inability of their  Ig  or 
TCR. genes to undergo rearrangement (26). Therefore, all the 
mature T  and B  cells in the CNAci-/-/RAG-2  -/-  chime- 
ras should be derived from the injected CNAot -/-  ES cells. 
Figure  1.  The  CNAa  gene 
was targeted by homologous  re- 
combination, and cells homozy- 
gous  for  this  mutation did  not 
produce  CNAo~  mP,  NA  or 
polypeptide.  (a)  Partial genomic 
structure  of  the  CNAot  gene 
(top), the targeting construct  for 
homologous recombination (mid- 
dle), and the targeted  allele (bot- 
tom). The neo gene was inserted 
into  an  exon  encoding  nucle- 
otides  572-717  of  the  mouse 
CNAc~  mlLNA  sequence  (8). 
The 1.2-kb EcoP, l fragment was 
used as a hybridization probe for 
Southern analyses  to identify ho- 
mologous  recombination events 
(see b).  The location  of several 
restriction  enzyme  sites  (E, 
EcoRI; M, MscI; M/, MluI) are 
indicated.  *Enzyme  site  in  the 
vector.  (b)  Southern  analyses of 
J1  ES  cell  DNA  (lane  I), 
CNAet +/- ES cell DNA (lane  2), 
and  CNAa  -/-  ES  cell  DNA 
(lane 3) digested with MscI and 
hybridized  with  the  1.2-kb 
probe  (a). The expected size for 
the endogenous  and the mutant 
band are  18 and 7.5 kb, respec- 
tively. (c) Northern analyses of total IkNA derived from J1  (lane 1), CNAet +/- (lane 2), and CNA~x  -/- (lane 3) ES cells using the 5' end ofcalcineurin 
Act cDNA (nucleotides 95-714) as the probe. (d) Western analyses  ofT cell extracts from wild-type (lane I) and mutant mice (lane 2) using CNAa-spe- 
cific antibodies. 
415  Zhang et al. Cakineurin Activity in CNAce -/- T  Cells.  The amounts of 
calcineurin  in T  cell  extracts derived from CNAIx  -/-  and 
wild-type  mice  were  compared  by Western  blotting  and 
enzyme activity assays. A  CNAoe-specific antibody only de- 
tected CNAo~ polypeptide in wild-type T  cell extracts, but 
not in CNAo~  -/-  T  cell extracts  (Fig.  1 d).  A  CNAI3-spe- 
cific antibody did not detect CNA[3 peptide in either wild- 
type or mutant T  cells,  even though this peptide could be 
readily detected in brain (our unpublished results). 
Calcineurin  activity  (okadaic  acid  resistant  and EGTA- 
sensitive  phosphatase  activity)  was  measured  in  the  same 
wild-type  and  CNAo~  -/-  T  cell  extracts  (32).  The  phos- 
phatase activity in CNAot -/- T  cell extracts was 34% of the 
activity found in wild-type T cell extracts (169 +  32 vs 500 + 
77 pmol substrate/min  per mg protein).  The residual  cal- 
cineurin-like activity in the mutant T  cells could be contrib- 
uted  by  other  calcineurin  isoforms  or  by  other  related 
phosphatases. The phosphatase activity in both the wild-type 
and  CNA~x -/-  T  cells  was  90-95%  inhibited  by  FK506. 
Our data,  consistent with previous findings,  suggested that 
o~ is the predominant isoform in T  cells.  In the absence of 
CNAoq CNA[3 does not seem to be increased￿9 
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Normal Development of T and B Lineage Cells.  The  com- 
position and distribution  of T  and B  cell lineage cells  were 
normal in the thymus, spleen, lymph nodes, and bone mar- 
row ofCNAoL  -/- mice based on staining with antibodies to 
TCR.oL~, TCP<yS, CD3,  CD4,  CD8,  MHC  class I and  II, 
Thy-1,  IL-2Roq B220,  IgM,  IgG,  IgD,  IgA, IgE,  CD23, 
$7, and CD5 (Fig. 2; data not shown). CNAIx  -/- mice had 
populations  of  double-negative  (CD4-CDS-),  double- 
positive  (CD4+CD8+),  and  single-positive  (CD4+CD8 - 
or CD4-CD8 +) thymocytes that were comparable to wild- 
type litter mates (Fig. 2; data not shown). Staining with dif- 
ferent V[3 antibodies  (VI35, VI36, VI38, V[39, V[~11, VI313, 
and VI314)  showed that V~  usage in the  CNAix -/-  thy- 
mus was similar to that in the wild-type thymus  (data not 
shown).  These findings indicated  that a functional CNA<x 
gene  is  not  required  for the  maturation  of either  T  or B 
lymphocytes. 
Defective  T  Cell Responses  to Protein Antigens.  To  deter- 
mine if CNAci is required  for a normal immune response, 
we  measured  the  responses  of wild-type  and  CNAo~  -/ 
mice to immunization with hapten-protein antigens. Wild- 
type and CNAo~  -/- mice with at least one H-2  b allele were 
Thymus 
Lymph  Node 
Lymph  Node 
Figure  2.  Normal development of T and B lineage 
cells in  CNAcl  -/-  mice. Thymocytes (a  and  b)  or 
lymph node cells (c-f) from wild-type (a, c, and e) or 
CNA~ -/-  (b, d, and f) mice of B6/129 background 
were stained with PE-CD4 and FITC-CD8  (a-d) or 
with PE-B220 and HTC-IgM (e and  f). 
416  T Cell Responses in Calcineurin  A<x-deficient Mice immunized  subcutaneously  with  TNP-OVA  (29).  10  d 
later, lymph node  cells were  harvested.  The  total number 
of lymph node cells and the percentages ofCD4 + or CD8 + 
T  cells  were  similar  in  the  immunized  wild-type  and 
CNAoe -/-  mice  (data  not  shown).  After restimulation in 
vitro with OVA,  T  ceils from wild-type mice proliferated 
much more rapidly than T  cells from CNAcx  -/-  mice (Fig. 
3  a; data not shown).  Addition of normal APCs or IL-2 to 
the in vitro cultures did not complement the proliferative 
defect ofCNA~x -/-  T  cells (Fig. 3  a). 
The  defect in the antigen-specific T  cell response could 
be caused either by a  defect in  CNAo~  -/-  T  cells or by a 
defect  in  other  cells  whose  function  is  required  for  the 
priming of antigen-specific T  cells as a result of immuniza- 
tion.  To  distinguish between the two possibilities, we im- 
munized CNAo~-/-/RAG-2 -/-  chimeras with TNP-OVA 
and restimulated the lymph node  cells with  the  immuno- 
gen  after  10  d.  CNAo~  -/-  T  cells  from  the  CNAo~-/-/ 
RAG-2 -/-  chimeras did not proliferate as well in response 
to OVA (Fig. 3  b).  In the CNAoL-/-/RAG-2  -/-  chimeras, 
only T  and B  cells were completely CNAcx -/-, while 90% 
of other cell types were derived from the RAG-2 -/-  blas- 
tocysts  that  were  CNAa +/+,  because  the  CNAcx -/-  ES- 
derived  cells  comprised  only ~10%  of the  chimeric  ani- 
mals, as judged by coat color contributions. This suggested 
that the defective in vivo antigen-specific T  cell response in 
CNAcx -/-  mice  was  caused  by  deficits in  T  cells per se, 
rather than  deficits in any other cell types involved in the 
initiation of immune response. 
Upon restimulation with OVA, the lymph node T  cells 
from immunized CNAcx -/-  mice secreted significantly less 
IL-2, IL-4, and IFN-'y than the lymph node T  cells from im- 
munized normal mice (Table 1). Primary antibody responses 
were also assessed in wild-type and CNAoL  -/-  mice immu- 
nized with TNP-OVA.  Similar titers ofanti-TNP antibod- 
ies  (IgG1  and  IgG2a)  were  found in the  serum  of immu- 
nized wild-type and CNAcx -/-  mice (data not shown). 
CNAa  -/-  T  Cells Respond Normally  to  Mitogens  In  Vitro 
and Remain Sensitive to  CsA and FK506.  We  tested  the 
responses of wild-type and CNAo~  -/-  T  cells to mitogenic 
stimulation with  PMA  plus  ionomycin,  ConA,  and  anti- 
CD3e antibodies. All three mitogens induced the CNAc~  -/- 
Table 1.  IL-2 and IFN-T secretion by Wild-type and CNAa -I- 
T  Cells 
Mouse No.  Genotype  IL-2  IFN-"/ 
2741  +/+  nd  799 
2752  + / +  nd  982 
2768  +/+  7.6  622 
2769  +/+  7.5  33 
2802  +/+  >16  537 
2838  +/+  15.4  358 
2841  +/+  >16  257 
2740  -/-  nd  0 
2751  -/-  nd  0 
2736  -/-  0.7  164 
2764  -/-  0.7  0 
2806  -/-  4.2  0 
2791  -/-  0.4  0 
IL-2 and IFN-~/production by T cells  from immunized wild-type and 
CNAcx  -/- mice. CNAoU- T cells  secreted significantly less IL-2 (av- 
erage units  of activity in wild type  =  12.5 vs  1.5  U  in CNAcx-/-; 
P <0.003) and IFN-~/(average units of  activity in wild type =  513 vs 27 
in CNAa-/-; P  <  0.005) than  the wild-type T  cells, nd, not deter- 
mined. 
T  cells to proliferate as rapidly as the wild-type T  cells (Fig. 
4).  Furthermore,  stimulated mutant  and wild-type T  cells 
produced the same amounts oflL-2 and IL-4 and expressed 
normal level of IL-2II, on the cell surface (data not shown). 
Nuclear factor of activated T  cells (NF-AT) was also trans- 
located into the nucleus after mitogen stimulation (data not 
shown).  Thus,  CNAcx -/-  T  cells appeared to be functional 
when stimulated by polyclonal mitogens in vitro. 
Calcineurin,  especially calcineurin  containing  the  As 
subunit, has been implicated as the target for the immuno- 
suppressive  drugs  CsA  and  FK506,  which  inhibit  TCR- 
mediated proliferation and IL-2 production by normal T  cells 
(33-36). We tested the drug sensitivity of the CNAa -/-  T 
cells. Cell proliferation and IL-2 and IL-4 production were 
inhibited  in  CNA~x  -/-  and  wild-type  T  cells  stimulated 
o 
o  4 
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Figure  3.  Antigen-specific prohferative response of 
T  cells measured by [3H]thymidine incorporation. All 
experiments were done in triplicate. (a) After wild-type 
(open symbols) and CNAoL  -/- (closed  symbols) mice were 
immunized (Materials  and Methods), lymph node cells 
were restimulated with OVA alone (squares);  OVA plus 
4  ￿  104  T  cell-depleted  and  irradiated  C57BL/6 
spleen cells as  exogenous APCs  (diamonds); or with 
OVA plus 10 U/nil exogenous IL-2 (circles). (b) After 
wild-type (open  squares) and CNAcx-/-RAG-2  -/- chi- 
meric  (closed squares) mice  were  immunized,  lymph 
node cells were restimulated with OVA. 
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Figure 4.  Response to mitogenic stimulation. Spleen cells and lymph 
node cells  from two wild-type (clear columns) and two CNAc~  -/  ~qlled  col- 
umns) mice of Black Swiss/129 background were stimulated with me- 
dium alone (-), 2.5 ng/ml PMA + 75 ng/ml ionomycin (P+I), 2.5 p~g/ 
ml Con A, soluble cxCD3e antibody (sCD3),  or plate-bound clCD3e an- 
tibody  (x-CD3).  60  h  after stimulation,  cultures  were  pulsed with 
[3H]thymidine for 6 h. Experiments were done in duplicate. 
with  PMA  plus  ionomycin,  ConA,  or  0tCD3e  antibody, 
CNAot  -/-  T  cells, and wild-type T  cells were both inhib- 
ited by CsA and  FK506,  as measured by proliferation and 
by  IL-2  and  IL-4  production  (Fig.  5;  data  not  shown). 
CNAot  -/-  T  cells were even more sensitive to these drugs 
than normal T  cells, with a  ICs0 two- to sevenfold lower 
than that of the wild-type T  cells. 
Discussion 
We have generated mice that lack CNAot by inactivating 
the  CNAoe  gene  (Fig.  1). We demonstrate here that there 
was >65% reduction ofcalcineurin activity in the CNAot  -/- 
T  lymphocytes. The residual calcineurin-like activity in the 
mutant  T  cells  is  likely to  be  contributed  by  other  cal- 
cineurin  isoforms  or  by  other  related  phosphatases.  Our 
data suggest, however, that 0t is the predominant isoform in 
T  cells; in the  absence of CNAot,  expression of CNA[3 is 
not increased (data not shown). 
T  and B  cell development appears to proceed normally 
in CNAot -/-  mice (Fig. 2; data not shown), indicating that 
a functional CNAoe  gene is not required for the maturation 
of these cells. The mutant mice have a defective T  cell re- 
sponse to antigen in vivo. Because this defective T  cell re- 
sponse could not be complemented by other cells supplied 
by RAG-2  /-  mice, we conclude that CNAot is required 
for in vivo antigen-specific T  cell responses. 
Even  though  CNAc~  is required for in  vivo T  cell re- 
sponse, it is not required for in vitro T  cell responses to mi- 
togens (Fig. 3  and 4; data not shown).  This result contrasts 
with previous findings implicating CNAot in TCR-medi- 
ated proliferation and IL-2 production (33-36). We do not 
know  the reason for the  discrepancy, but  our findings do 
suggest that in vitro T  cell responses to otCD3e antibody or 
ConA may not reflect the ability of T  cells to  respond to 
antigens in vivo. 
CNAot -/-  T  cells  were  sensitive  to  FK506  and  CsA 
(Fig.  5;  data  not  shown)  suggesting  that  other  molecules 
can mediate the  immunosuppressive  effect of these  drugs. 
One  of these proteins is most likely to be  CNA[3.  When 
CNA[3 is over expressed in Jurkat cells, it has the same bio- 
logical activities as  over-expressed CNAot  (O'Keefe,  S.J., 
unpubhshed  results). Furthermore,  90-95%  of the residual 
calcineurin activity found  in  CNAc~ -/-  T  cells, which  is 
most likely contributed by CNAJ], is FKS06 sensitive. Both 
of these  observations suggest  that  CNA[3  can  serve  as  an 
immunosuppressive  drug  target in  the  CNAot  -/-  T  cells. 
We cannot, however, rule out the possibility that there are 
other  drug  targets,  since  CsA and  FK506  were  shown  to 
inhibit an antigen-specific response in the absence of a cal- 
cium signal (37).  CNA~t -/-  T  cells had increased sensitiv- 
ity to both CsA and FK506,  suggesting that CNAot is the 
primary target of drug-immunophilin complexes, presum- 
ably because  of the  predominant  presence  of the  CNAot 
protein in T  cells. 
The finding that CNA0t -/-  nfice have  a marked T  cell 
deficiency  suggests  that  CNAcx  may  be  a  relevant  cal- 
cineurin, isoform  that  mediates  immunosuppression  after 
treatment  with  CsA or FK506.  We suggest that  CsA and 
FKS06  also  target  other  proteins,  which  are  sufficient to 
mediate the  in vitro  T  cell responses  to  mitogens.  How- 
ever, these other CsA and FK506 target proteins cannot re- 
place  CNAct's  function  in  vivo.  Furthermore,  studies  of 
CNAot  -/-  mice should elucidate other roles for CNAcx in 
physiology and pathobiology. 
j  o 
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Figure 5.  Proliferation of CNAcx  -/- and wild-type 
T  cells in the presence of CsA and FK506. 2 ￿  104 
wild-type (clear diamonds) or CNAcx  -/- (solid diamonds) 
lymph node cells  were stimulated with 10 ng/ml PMA 
+  300 ng/ml ionomycin in the presence of different 
concentrations of CsA (a)  or FK506 (b). 60  h  after 
stimulation, cultures were pulsed with  [3Hlthymidine 
for 6 h. Experiments were done in triplicate. 
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